A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial to Characterize the Efficacy and Safety of TEV-53408 in Adults with Coeliac Disease while undergoing Oral Gluten Exposure.
The purpose of this trial is to evaluate the efficacy and safety of TEV-53408 in adult participants who have coeliac disease with minimal enteropathy and are maintaining a gluten-free diet.
If eligible for the study, your participation is expected to be up to 87 weeks (including the Screening Period).
Please contact CDH Research Institute on 07 5408 0900 for additional information or use the email link below. You can also share details of this study to social media via the links below?
